Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. June 19, 202489.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | AN2 Therapeutics Inc. | Open-market purchase | +2,098 | $5.53 | $11,602 |
| May 28, 2025 | AN2 Therapeutics Inc. | Open-market purchase | +8,610 | $1.18 | $10,160 |
Questions about Margaret M. FitzPatrick
What boards is Margaret M. FitzPatrick on?
Margaret M. FitzPatrick sits on the boards of AN2 Therapeutics Inc. and Vistagen Therapeutics Inc.
How long has Margaret M. FitzPatrick served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.